Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The Real Value Of A Breakthrough Therapy Designation:

<< Previous

Bullboard Posts

Next >>

Comment by Bigkahuna57on Oct 05, 2024 10:27am

235 Views

Post# 36254433

RE:The Real Value Of A Breakthrough Therapy Designation:

@O12009,

Thank you for bringing this source and information back, so everyone can see for themselves the value of BTD. Here's the link original Seeking Alpha article from 2019.

https://seekingalpha.com/article/4314267-real-value-of-breakthrough-therapy-designation

For all the TLT anti-cancer freethinkers out there - don't let those that state they know more about running this company and developing a multiple indications to address cancer, cloud the facts. THEY have done nothing in the Bio-Medical industry except reading about it.

Good Luck to All.
Regards, BK

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments